Acting for Structure Therapeutics Inc. a clinical stage global biological company in its US$185 million NASDAQ listing, and US$300 million private placement equity financing
Acting for Structure Therapeutics Inc. a clinical stage global biological company in its US$185 million NASDAQ listing, and US$300 million private placement equity financing